Harvard School of Public Health: A Versatile Vessel for Next-Gen Therapeutics
July 23, 2020
July 23, 2020
CAMBRIDGE, Massachusetts, July 23 -- Harvard University's T.H. Chan School of Public Health issued the following news release:
Harvard University's Office of Technology Development (OTD) and the Harvard T.H. Chan School of Public Health announced the launch of Vesigen Therapeutics, a startup company that aims to overcome the challenge of delivering next-generation therapeutics, such as gene-editing complexes, RNA molecules, and other large proteins, to intracellular targets in speci . . .
Harvard University's Office of Technology Development (OTD) and the Harvard T.H. Chan School of Public Health announced the launch of Vesigen Therapeutics, a startup company that aims to overcome the challenge of delivering next-generation therapeutics, such as gene-editing complexes, RNA molecules, and other large proteins, to intracellular targets in speci . . .